FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2473158767> ?p ?o ?g. }

• W2473158767 endingPage "594" @default.
• W2473158767 startingPage "590" @default.
• W2473158767 abstract "Dexmedetomidine Diminishes Halothane Anesthetic Requirements in Rats Through a Postsynaptic Alpha 2 Adrenergic Receptor. By Segal IS, Vickery RG, Walton JK, Doze VA, and Maze M. ANESTHESIOLOGY 1988; 125:590-4. Abstract reprinted with permission.The effect of 4(5)-[1-(2,3-dimethylphenyl)ethyl]imidazole (medetomidine), the α2 adrenergic agonist, on anesthetic requirements was investigated in rats anesthetized with halothane. Halothane MAC was determined before and after either dexmedetomidine (D-enantiomer) or levomedetomidine (L-enantiomer) 10, 30, and 100 μg/kg, or vehicle intraperitoneally. There was a dose-dependent increase in MAC with the D-, but not the L-, stereoisomer. At the highest dose of dexmedetomidine (100 μg/kg), halothane could be discontinued for up to 30 min with no response to tail clamping. To determine whether α2 adrenoreceptors mediated this effect of dexmedetomidine on MAC, cohorts of rats were pretreated with idazoxan, 10 mg/kg intraperitoneally, a highly selective α2 antagonist. This completely prevented the reduction of MAC caused by dexmedetomidine. To determine whether the reduction of MAC caused by dexmedetomidine was mediated in part through either opiate or adenosine receptors, groups of rats were pretreated with either naltrexone, 5 mg/kg intraperitoneally, an opiate antagonist, or 8-phenyltheophylline, 2.5 mg/kg intraperitoneally, an A1 adenosine antagonist. These two pretreatments did not alter the reduction of MAC by dexmedetomidine. To determine whether postsynaptic mechanisms mediate the anesthetic effect of dexmedetomidine, rats were depleted of central catecholamine stores with either n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine or reserpine and α-methyl-para-tyrosine, and MAC was determined before and after each dose of dexmedetomidine. While the catecholamine-depleted rats had a lower basal MAC than the vehicle controls, there was still a profound reduction in halothane MAC after administration of dexmedetomidine. The reduction of MAC by dexmedetomidine was blocked with idazoxan in the catecholamine-depleted rats. These data indicate that the reduction of MAC caused by dexmedetomidine is mediated through α2 adrenoreceptors with no apparent involvement of either opiate or A1 adenosine receptors. Data from catecholamine-depleted rats suggest that the mediating mechanism must involve site(s) other than or in addition to the presynaptic α2 adrenergic receptors on noradrenergic neurons. The authors conclude that central postsynaptic α2 adrenergic receptors mediate a significant part of the reduction of anesthetic requirements caused by dexmedetomidine." @default.
• W2473158767 created "2016-07-22" @default.
• W2473158767 creator A5065301160 @default.
• W2473158767 date "2016-09-01" @default.
• W2473158767 modified "2023-10-18" @default.
• W2473158767 title "From Bench to Bedside and Back Again" @default.
• W2473158767 cites W1525081124 @default.
• W2473158767 cites W1976315511 @default.
• W2473158767 cites W1982139505 @default.
• W2473158767 cites W1984552110 @default.
• W2473158767 cites W1988468898 @default.
• W2473158767 cites W1997386700 @default.
• W2473158767 cites W1999485470 @default.
• W2473158767 cites W2000018178 @default.
• W2473158767 cites W2017573472 @default.
• W2473158767 cites W2021570089 @default.
• W2473158767 cites W2027003967 @default.
• W2473158767 cites W2033479223 @default.
• W2473158767 cites W2051950456 @default.
• W2473158767 cites W2067978100 @default.
• W2473158767 cites W2073279176 @default.
• W2473158767 cites W2082311304 @default.
• W2473158767 cites W2084453889 @default.
• W2473158767 cites W2088267315 @default.
• W2473158767 cites W2143449404 @default.
• W2473158767 cites W2149509906 @default.
• W2473158767 cites W2169567979 @default.
• W2473158767 cites W2206541338 @default.
• W2473158767 cites W2268066485 @default.
• W2473158767 cites W2296910921 @default.
• W2473158767 cites W2301769892 @default.
• W2473158767 cites W2515708122 @default.
• W2473158767 doi "https://doi.org/10.1097/aln.0000000000001214" @default.
• W2473158767 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5394927" @default.
• W2473158767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27348818" @default.
• W2473158767 hasPublicationYear "2016" @default.
• W2473158767 type Work @default.
• W2473158767 sameAs 2473158767 @default.
• W2473158767 citedByCount "9" @default.
• W2473158767 countsByYear W24731587672017 @default.
• W2473158767 countsByYear W24731587672018 @default.
• W2473158767 countsByYear W24731587672020 @default.
• W2473158767 countsByYear W24731587672022 @default.
• W2473158767 countsByYear W24731587672023 @default.
• W2473158767 crossrefType "journal-article" @default.
• W2473158767 hasAuthorship W2473158767A5065301160 @default.
• W2473158767 hasBestOaLocation W24731587672 @default.
• W2473158767 hasConcept C123605464 @default.
• W2473158767 hasConcept C126322002 @default.
• W2473158767 hasConcept C170493617 @default.
• W2473158767 hasConcept C2776312488 @default.
• W2473158767 hasConcept C2776814716 @default.
• W2473158767 hasConcept C2776885963 @default.
• W2473158767 hasConcept C2776932660 @default.
• W2473158767 hasConcept C2776991684 @default.
• W2473158767 hasConcept C2777953023 @default.
• W2473158767 hasConcept C2778162923 @default.
• W2473158767 hasConcept C2778938600 @default.
• W2473158767 hasConcept C2779520467 @default.
• W2473158767 hasConcept C2780648677 @default.
• W2473158767 hasConcept C2780939551 @default.
• W2473158767 hasConcept C2781302539 @default.
• W2473158767 hasConcept C42219234 @default.
• W2473158767 hasConcept C71924100 @default.
• W2473158767 hasConcept C84393581 @default.
• W2473158767 hasConcept C98274493 @default.
• W2473158767 hasConceptScore W2473158767C123605464 @default.
• W2473158767 hasConceptScore W2473158767C126322002 @default.
• W2473158767 hasConceptScore W2473158767C170493617 @default.
• W2473158767 hasConceptScore W2473158767C2776312488 @default.
• W2473158767 hasConceptScore W2473158767C2776814716 @default.
• W2473158767 hasConceptScore W2473158767C2776885963 @default.
• W2473158767 hasConceptScore W2473158767C2776932660 @default.
• W2473158767 hasConceptScore W2473158767C2776991684 @default.
• W2473158767 hasConceptScore W2473158767C2777953023 @default.
• W2473158767 hasConceptScore W2473158767C2778162923 @default.
• W2473158767 hasConceptScore W2473158767C2778938600 @default.
• W2473158767 hasConceptScore W2473158767C2779520467 @default.
• W2473158767 hasConceptScore W2473158767C2780648677 @default.
• W2473158767 hasConceptScore W2473158767C2780939551 @default.
• W2473158767 hasConceptScore W2473158767C2781302539 @default.
• W2473158767 hasConceptScore W2473158767C42219234 @default.
• W2473158767 hasConceptScore W2473158767C71924100 @default.
• W2473158767 hasConceptScore W2473158767C84393581 @default.
• W2473158767 hasConceptScore W2473158767C98274493 @default.
• W2473158767 hasIssue "3" @default.
• W2473158767 hasLocation W24731587671 @default.
• W2473158767 hasLocation W24731587672 @default.
• W2473158767 hasLocation W24731587673 @default.
• W2473158767 hasLocation W24731587674 @default.
• W2473158767 hasLocation W24731587675 @default.
• W2473158767 hasOpenAccess W2473158767 @default.
• W2473158767 hasPrimaryLocation W24731587671 @default.
• W2473158767 hasRelatedWork W111747611 @default.
• W2473158767 hasRelatedWork W152895892 @default.
• W2473158767 hasRelatedWork W1975131753 @default.
• W2473158767 hasRelatedWork W2033479223 @default.
• W2473158767 hasRelatedWork W2057126625 @default.

• next